L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting-edge research, science and education on skin and hair care.
SScalp MicrobiomeSeborrheic DermatitisSensitive SkinSkin AgeingSkin & MaternitySkin & OncologySkin & PollutionSkin BarrierSkin LesionsSkin MicrobiomeSkin of Color
VVitiligo
XXerosis(DrySkin)
Discover scientific content related to skin and hair care through different formats - articles, videos, expert interviews, publications, clinical studies, etc...Become a member
We empower each and everyone with the most advances skincare management. Our brands offer a range of skincare and haircare products to respond to all expectations linked to beauty and skin health. From skin pathologies and aesthetic concerns and from the most accessible ranges to the most premium ones.Become a member
Effectively cleanses, hydrates, and helps restore the protective skin barrier.
Eligible Patients
Patients of all skin types, including sensitive skin. Best for normal to dry skin. Suitable for children and atopic skin as part of a monotherapy or adjunctive routine with CeraVe Moisturising Cream.
Application
Apply to wet hands and massage into the skin, then rinse thoroughly.
Recommended to use with CeraVe Moisturising Cream or Lotion.
Texture
Lightweight, non-foaming, creamy lotion cleanser.
Hydrating Cleanser + Moisturising Cream Efficacy
A CeraVe Routine Significantly Improved Patient Symptoms in a Global Diabetic Study1
Protocol: In a multicentre study, 528 subjects (ages 18-75 years) from 19 countries with diabetes mellitus-related xerosis used the CeraVe Hydrating Cleanser and Moisturising Cream regimen twice daily for 4 weeks. Clinicians assessed dry skin symptoms using the five-point Dry Skin Classification Scale (DSCS) at baseline and week 4.
A CeraVe Routine Significantly Improved Signs and Symptoms of Mature Xerosis2
Protocol: A 4-week, single-centre clinical study was conducted on 30 women and men, ages 70+, with evidence of xerosis and/
or desquamation having a systemic disease and/or using concomitant medications with the side effect of xerosis. Hydrating Cleanser was used at least once daily on the body and Moisturising Cream was applied twice daily to the body. Efficacy was evaluated by clinical grading at baseline and week 4. Photographs and subject self-assessment evaluations were conducted at baseline and week 4.
Adjunctive Acne
Combining CeraVe Hydrating Cleanser and Moisturising Lotion helped support the tolerability of a prescription acne regimen.3
65% of patients reported no stinging and 55% reported no dryness when using CeraVe Hydrating Cleanser and Moisturising Lotion with a prescription acne regimen.3
Protocol: A 12-week, single-centre, open-label clinical study was conducted on 20 women and men, ages 13–49, with mild to moderate facial acne. Hydrating Cleanser and Moisturising Lotion were applied twice daily; followed by clindamycin phosphate 1.2%/benzoyl peroxide 2.5% in the morning and micronized tretinoin 0.05% gel in the evening. Efficacy and tolerability evaluations were conducted at baseline and at weeks 2, 4, 8, and 12.
Atopic Dermatitis
Almost 3 out of 4 subjects (74%) with mild to moderate atopic dermatitis were cleared of symptoms after 6 weeks of using the regimen of CeraVe Hydrating Cleanser and Moisturising Cream.4
Protocol: In a randomised study, 151 subjects (118 subjects over 12) with mild to moderate atopic dermatitis (AD) used the CeraVe Hydrating Cleanser and Moisturising Cream regimen twice daily for 6 weeks. A dermatologist assessed treatment outcomes by comparing AD severity at baseline (day 0) versus the end of treatment (day 42).
Eczema
CeraVe Hydrating Cleanser helps accelerate skin healing and eczema symptom clearance when in combination with fluocinonide cream 0.05% 5
Protocol: A 4-week study, on 60 women, men, and children, ages 5 to 80, with mild to moderate eczema, split in 3 groups. Subjects in Group 1 applied topical 0.05% fluocinonide cream to their entire face twice daily plus a mild cleansing bar as needed. Subjects in Group 2 applied topical 0.05% fluocinonide cream to their entire face twice daily plus Hydrating Cleanser as needed. Subjects in Group 3 applied topical 0.05% fluocinonide cream and Moisturizing Cream to their entire face twice daily plus Hydrating Cleanser as needed. Efficacy and tolerability evaluations were conducted at baseline, weeks 1, 2, and 4.
Diabetes-Related Xerosis
93% of subjects demonstrated ≥1 point improvement in roughness/scaling after 4 weeks1
91% of subjects demonstrated ≥1 point improvement in fissures after 4 weeks1
Over 75% of subjects improved in at least one quality of life parameter: feelings of embarrassment, quality of their social life, and quality of their work/study1
Subjects were compliant with 91% of expected CeraVe regimen applications and reported intentions to continue use outside of the study1
Protocol: In a multicentre study, 528 subjects (ages 18-75 years) from 19 countries with diabetes mellitus-related xerosis used the CeraVe Hydrating Cleanser and Moisturising Cream regimen twice daily for 4 weeks. Clinicians assessed dry skin symptoms using the five-point Dry Skin Classification Scale (DSCS) at baseline and week 4.
Mature Xerosis
93% of subjects felt their dry skin no longer limited their daily activities of work, physical activity, or rest2
90% of subjects felt their dry skin no longer impacted their social or leisure activities2
70% of subjects felt their dry skin was no longer embarrassing or awkward2
Protocol: A 4-week, single-centre clinical study was conducted on 30 women and men, ages 70+, with evidence of xerosis and/or desquamation having a systemic disease and/or using concomitant medications with the side effect of xerosis. Hydrating Cleanser was used at least once daily on the body and Moisturising Cream was applied twice daily to the body. Efficacy was evaluated by clinical grading at baseline and week 4. Photographs and subject self-assessment evaluations were conducted at baseline and week 4.